Hypercholeresis induced by norchenodeoxycholate in biliary fistula rodent

Area of Science:

• Hepatology
• Bile Acid Metabolism
• Physiology

Background:

• Bile acids are crucial for digestion and maintaining liver health.
• Understanding how synthetic bile acids affect bile formation is key to developing new therapies.

Purpose of the Study:

• To investigate the biliary recovery, hepatic biotransformation, and choleretic effects of norchenodeoxycholic acid (nor-CDC) and its taurine conjugate.
• To compare the effects of nor-CDC with natural chenodeoxycholic acid (CDC).

Main Methods:

• Infusion of nor-CDC, its taurine conjugate, and CDC in anesthetized hamsters, rats, and guinea pigs with biliary fistulas.
• Analysis of biliary recovery, hepatic biotransformation products (amidation, hydroxylation, conjugation), bile flow, and bicarbonate secretion.

Main Results:

• Nor-CDC showed slower biliary recovery and complex hepatic biotransformation compared to CDC, with less amidation.
• Nor-CDC induced significant hypercholeresis in hamsters and rats, far exceeding that of natural bile acids, with increased bicarbonate secretion.
• The taurine conjugate of nor-CDC and nor-CDC in guinea pigs did not exhibit these pronounced hypercholeretic effects.

Conclusions:

• Shortening the bile acid side chain to create nor-CDC alters its hepatic metabolism and results in potent bicarbonate-rich choleresis.
• Nor-CDC's unique properties suggest novel mechanisms of bile formation beyond current theories.